|
2026
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central ner... |
|
2025
|
G/S
|
Promoting public interest and awareness of cardiovascular disease providing educational informati... |
|
|
G/S
|
Promoting public interest in and raising awareness of cardiovascular disease
Providing medical in... |
|
|
G/S
|
Pharmaceutical preparations. |
|
|
Invention
|
Pyrazolopyrimidine pde9 inhibitors.
The present invention is directed to amino and alkyl pyrazol... |
|
|
G/S
|
Providing medical information |
|
|
Invention
|
Labeling shell for a drug vial.
In one aspect of the subject invention, a labeling shell is prov... |
|
|
Invention
|
Process for preparing dipeptide compounds. The present invention relates to efficient synthetic p... |
|
|
Invention
|
Process for preparing lipidated peptide and its intermediates. The instant invention is directed ... |
|
|
Invention
|
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, p... |
|
|
Invention
|
Antibody neutralizing human respiratory syncytial virus.
The present invention relates to monocl... |
|
|
Invention
|
Combination therapy comprising an immunoconjugate for the treatment of gastroesophageal cancer. T... |
|
|
Invention
|
Chemoselective reduction of cysteine-engineered antibodies for preparation of antibody drug conju... |
|
|
Invention
|
Use of an immunoconjugate for the treatment of gastroesophageal cancer. The present disclosure re... |
|
|
Invention
|
Anti-cancer combination therapies comprising ctla-4 and pd-1 blocking agents.
Anti-cancer combin... |
|
|
Invention
|
Processes for making stable nanoemulsion adjuvants. The present disclosure provides a process to ... |
|
|
Invention
|
Ecteinascidin derivatives and methods of use thereof as antitumor agents. The present disclosure ... |
|
|
Invention
|
Small molecule protein degraders of kras g12d mutant. Compounds or their pharmaceutically accepta... |
|
|
Invention
|
Combination of anti-b7-h3 antibody-drug conjugate and androgen receptor signaling inhibitor. In s... |
|
|
Invention
|
Protein degraders of kras g12d mutant. Compounds or their pharmaceutically acceptable salts can m... |
|
|
Invention
|
Small molecule inhibitors of kras proteins. Compounds of Formula (I) or their pharmaceutically ac... |
|
|
G/S
|
Pharmaceutical preparations for prevention or treatment of infectious diseases Providing medical ... |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of infectious diseases Providing med... |
|
|
Invention
|
Engineered phenylalanine ammonia lyase polypeptides and methods of making and using the same. The... |
|
|
Invention
|
Process for preparing amino phenyl compounds. The instant invention is directed to an efficient a... |
|
|
Invention
|
Granzyme b pet imaging agents. The invention is directed to compounds of Formula (I) and their ph... |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, canc... |
|
|
Invention
|
Use of conjugate in treating tumor disease and method. 12m13m24m3γγ-A Formula (I) |
|
|
Invention
|
Use of an immunoconjugate for the treatment of gastric cancer. The present disclosure relates to ... |
|
|
Invention
|
Crystals of anti-human tau monoclonal antibody. Crystals of an antibody that specifically binds t... |
|
|
Invention
|
Polypeptides for bioconjugation. Disclosed are polypeptides that can be used for bioconjugation. ... |
|
|
Invention
|
System for medicinal supply monitoring and management with controlled packaging of medicinal prod... |
|
|
Invention
|
System for medicinal supply monitoring and management with digital display labeling.
A medicinal... |
|
|
Invention
|
System for medicinal supply monitoring and management for pooled medicinal product across studies... |
|
|
Invention
|
System for medicinal supply monitoring and management. A medicinal supply management system manag... |
|
|
Invention
|
N-oxide derivatives as selective cytotoxic agents. The present disclosure is directed to N-oxide ... |
|
|
Invention
|
Modulation of cell growth and viability using nucleoside transport inhibitors, inhibitors of aden... |
|
|
G/S
|
Pharmaceutical preparations, namely, anti-infectives and antivirals |
|
2024
|
Invention
|
Process for preparing beta 3 agonists and intermediates.
The application is directed to efficien... |
|
|
G/S
|
pharmaceutical preparations for veterinary use, namely, anti-inflammatories, insecticides, and ho... |
|
|
G/S
|
Pharmaceutical preparations for use in Oncology |
|
|
G/S
|
Pharmaceutical preparations for use in oncology |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of bone, cardiovascular, central ner... |
|
|
G/S
|
pharmaceutical preparations, namely, anti-infectives and antivirals providing medical information... |
|
|
G/S
|
pharmaceutical preparations, namely, anti-infectives and antivirals; human vaccine preparations p... |
|
|
G/S
|
Pharmaceutical preparations, namely, anti-infectives and antivirals providing medical information... |
|
|
Invention
|
Communication generation with artificial intelligence system.
A system retrieves, from one or mo... |
|
|
Invention
|
Enclosure for mitigation of leakage by syringe assembly.
A splash guard engages to a syringe ass... |
|
|
G/S
|
Pharmaceuticals and vaccines for human and veterinary use;
medicinal, pharmaceutical, therapeuti... |
|
|
Invention
|
Needle uncapping device.
A needle uncapping device enables safe removal and replacement of a syr... |
|
|
Invention
|
Tablet collection device.
A pneumatic tablet collection device including a tablet collector, a p... |
|
2023
|
Invention
|
Neutralization antibody assay method.
This disclosure relates generally to an assay to determine... |
|
|
Invention
|
Polypeptides effective against multiple coronaviruses.
Disclosed are single-domain antibodies th... |
|
|
Invention
|
Methods for determining one or more critical quality attributes of co-formulated antibodies.
The... |
|
|
Invention
|
Macrocyclic peptides targeting kras.
The invention provides compounds of Formula (I) or pharmace... |
|
|
Invention
|
Immunogenic compositions for herpes simplex virus proteins.
The disclosure provides live attenua... |
|
|
Invention
|
Genome wide tumor derived gene expression based signatures associated with poor prognosis for mel... |
|
|
Invention
|
Disruption of kdm4a in t cells to enhance immunotherapy.
The application provides modified immun... |
|
|
Invention
|
Method for sustained delivery of mrna vaccines.
The invention relates to a method of treating a ... |
|
|
Invention
|
Methods for treating cancer, or von-hippel lindau disease using a combination of a tigit antagoni... |
|
|
Invention
|
Ripk1 inhibitors and methods of use.
Described herein are compounds of Formula 1 or a pharmaceut... |
|
|
Invention
|
Inhibitors of msba as antibiotics, pharmaceutical compositions, and uses thereof.
The present di... |
|
|
Invention
|
Macrocycles as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof.
The present inve... |
|
|
Invention
|
Anti-integrin antibodies and uses thereof.
The integrin family of cell adhesion molecules has em... |
